Category: Reagents

Active filters

Reference: 13638-5

An orexin 1 and orexin 2 receptor antagonist (Kis = 4.7 and 0.9 nM, respectively); decreases the latency to persistent NREM and REM sleep and increases the duration of NREM and REM sleep in male rats when administered at a dose of 100 mg/kg; does not impair spatial learning and memory in the Morris water maze at 300 mg/kg

Reference: 10006326-1

A prodrug form of cysteine with antioxidant activity; reduces TNF-α-induced increases in IL-6 and CCL2 expression in ARPE-19 human retinal pigment epithelial cells at 0.5 mM; increases liver GSH levels in fasted, but not fed, mice at 6.5 mmol/kg; reduces ROS production in BALF and decreases plasma extravasation in the lungs, as well as reverses decreases in HIF-1α levels in a mouse model of allergic asthma at 80 and 160 mg/kg

Reference: A1932-10

NMDA receptor antagonist/AChE inhibitor

Reference: 13832-1

A regioisomeric resveratrol metabolite that may be used as a reference standard for accurate determination of the metabolic profile of resveratrol

Reference: 10006326-10

A prodrug form of cysteine with antioxidant activity; reduces TNF-α-induced increases in IL-6 and CCL2 expression in ARPE-19 human retinal pigment epithelial cells at 0.5 mM; increases liver GSH levels in fasted, but not fed, mice at 6.5 mmol/kg; reduces ROS production in BALF and decreases plasma extravasation in the lungs, as well as reverses decreases in HIF-1α levels in a mouse model of allergic asthma at 80 and 160 mg/kg

Reference: A1932-5.1

NMDA receptor antagonist/AChE inhibitor

Reference: 13832-5

A regioisomeric resveratrol metabolite that may be used as a reference standard for accurate determination of the metabolic profile of resveratrol

Reference: 10006326-25

A prodrug form of cysteine with antioxidant activity; reduces TNF-α-induced increases in IL-6 and CCL2 expression in ARPE-19 human retinal pigment epithelial cells at 0.5 mM; increases liver GSH levels in fasted, but not fed, mice at 6.5 mmol/kg; reduces ROS production in BALF and decreases plasma extravasation in the lungs, as well as reverses decreases in HIF-1α levels in a mouse model of allergic asthma at 80 and 160 mg/kg

Reference: A1932-25

NMDA receptor antagonist/AChE inhibitor